tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Neuren Pharmaceuticals Issues New Securities to Strengthen Market Position
PremiumCompany AnnouncementsNeuren Pharmaceuticals Issues New Securities to Strengthen Market Position
16d ago
Neuren Expands NNZ-2591 Pipeline to Include SYNGAP1-Related Disorder
Premium
Company Announcements
Neuren Expands NNZ-2591 Pipeline to Include SYNGAP1-Related Disorder
21d ago
Neuren Pharmaceuticals Sees Robust Growth in DAYBUE Sales for Q2 2025
Premium
Company Announcements
Neuren Pharmaceuticals Sees Robust Growth in DAYBUE Sales for Q2 2025
21d ago
Neuren Pharmaceuticals Secures US Patent for Pitt Hopkins Syndrome Treatment
PremiumCompany AnnouncementsNeuren Pharmaceuticals Secures US Patent for Pitt Hopkins Syndrome Treatment
2M ago
Neuren Pharmaceuticals Announces Cessation of Securities
Premium
Company Announcements
Neuren Pharmaceuticals Announces Cessation of Securities
2M ago
Neuren Pharmaceuticals Completes AUD 49.99 Million Share Buy-Back
Premium
Company Announcements
Neuren Pharmaceuticals Completes AUD 49.99 Million Share Buy-Back
2M ago
Neuren Pharmaceuticals Updates on Share Buy-Back Program
PremiumCompany AnnouncementsNeuren Pharmaceuticals Updates on Share Buy-Back Program
3M ago
Neuren Pharmaceuticals Updates on Securities Buy-Back Program
Premium
Company Announcements
Neuren Pharmaceuticals Updates on Securities Buy-Back Program
3M ago
Neuren Pharmaceuticals Updates on Share Buy-Back Program
Premium
Company Announcements
Neuren Pharmaceuticals Updates on Share Buy-Back Program
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100